The Gap, Inc.GPSNYSE

Loading chart...

52-Week Range10-31

9.71Current 24.5530.75

Want to monitor GPS?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

Total Assets

Cash vs Debt

Operating Cash Flow

Free Cash Flow

doris and don fisher opened the first gap store in 1969.

Retail Trade

Family Clothing Stores

Sonia Syngal

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

HR tech firm Rippling raises new funding at $16.8 billion valuation, no IPO plans

Innospec: Oilfield Services Bound For A Recovery

Ilika boss explains significant of first commercial Stereax electrodes order - ICYMI

4 'Safer' Dividend Buys In Barron's 23 Better March Bets Than T-Bills

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

Ollie's Bargain Outlet Analysts Slash Their Forecasts After Q4 Results

Pan African CEO on Tennant Creek consolidation deal - ICYMI

These Analysts Cut Their Forecasts On Dick's Sporting Following Q4 Earnings

Want Safe Dividend Income in 2026 and Beyond? Invest in the Following 2 Ultra-High-Yield Stocks

Why March 16 Could Be a Big Day for the Stock Market

Vaalco Energy: Lucky Break

The Bank of England had a plan, but the Middle East could change everything

Sanmina: ZT Systems Doubles Revenue, Margins Hold, And The Selloff Is Unjustified

China International Supply Chain Expo Unveils AI Zone as 100-Day Countdown Begins With 500+ Exhibitors

Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD

Avoro Capital Advisors LLC Trims Position in Alkermes plc $ALKS

Avoro Capital Advisors LLC Takes $4.58 Million Position in Tango Therapeutics, Inc. $TNGX

Avoro Capital Advisors LLC Cuts Stock Position in MoonLake Immunotherapeutics $MLTX

Avoro Capital Advisors LLC Trims Stock Position in BioCryst Pharmaceuticals, Inc. $BCRX

Avoro Capital Advisors LLC Makes New Investment in Oruka Therapeutics, Inc. $ORKA

About